AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung
CompletedOBSERVATIONAL
Enrollment
1,107
Participants
Timeline
Start Date
March 14, 2013
Primary Completion Date
May 31, 2017
Study Completion Date
May 31, 2017
Conditions
Non-Squamous Non-Small Cell Lung Cancer
Trial Locations (1)
04103
Universität Leipzig; Medizinische Klinik und Poliklinik I, Abteilung Pneumologie, Leipzig
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT01827852 - AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung | Biotech Hunter | Biotech Hunter